Drug Trial Radar · NCT05591755
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
Last checked: Nov 19, 2026Latest source record: Jul 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
229
Actual
Start
Nov 18, 2022
Primary completion
Aug 9, 2023
Study completion Aug 9, 2023
Sponsor
- Lead sponsor
- Bausch & Lomb IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Oct 24, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy of Combo compared to its individual components and compared to vehicle in a population of subjects with seasonal allergic conjunctivitis.
Conditions
- Seasonal Allergic Conjunctivitis
Interventions
Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic SolutionDrug
Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution
Ketotifen fumarate ophthalmic solution 0.035%Drug
Ketotifen fumarate ophthalmic solution 0.035%
Brimonidine tartrate ophthalmic solution 0.025%Drug
Brimonidine tartrate ophthalmic solution 0.025%
Experimental: Vehicle ophthalmic solutionDrug
Experimental: Vehicle ophthalmic solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ocular Itching Symptom ScoreTime frame: Assessed up to 480 minutes post-instillation of assigned IP
- Ocular Redness Measured by Ocular Itching ScaleTime frame: Assessed up to 480 minutes post-instillation of assigned IP
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
104 Butchertown Clinical Trials
Louisville, Kentucky
101 Andover Eye Associates
Andover, Massachusetts
105 - Advancing Vision Research
Goodlettsville, Tennessee
102 Total Eye Care, PA
Memphis, Tennessee
108 Emerson Clinical Research Institute Inc.
Falls Church, Virginia
107 Virginia Eye Institute
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.